Clinical Research

Mylan Inc.

Address
1000 Mylan Boulevard

Sponsor Overview

assignment
2
sponsored trials
science
2
molecules
location_city
15
research centres
public
1
country
person_search
15
investigators

Specializations

Major Depressive Disorder

Clinical research activity is centered on major depressive disorder, with attention to patients whose symptoms remain insufficiently controlled by existing antidepressant therapy. The sponsor’s studies examine both oral and injectable approaches used alongside ongoing antidepressant treatment.

  • Adjunctive antidepressant treatment
  • Treatment-resistant depression
  • Depressive symptom reduction

Outcomes are focused on changes in established depression rating scales and the broader management of persistent depressive symptoms.

Psychiatric Therapeutics

The sponsor’s therapeutic interest lies in psychiatric medicine, particularly interventions intended to enhance response in depressive disorders. The funded trials reflect a focus on add-on treatment strategies within routine mental health care.

  • Depression treatment augmentation
  • Mood disorder management
  • Symptom rating assessments

This area of research emphasizes clinically relevant improvement in mood symptoms for patients already receiving standard antidepressant therapy.

Oral and Injectable Formulations

Research activity includes both tablet and intramuscular formulations, indicating interest in different delivery routes for supportive treatment in depression. The sponsor’s trials assess whether these formulations can provide benefit as adjuncts to ongoing pharmacologic care.

  • Oral therapy
  • Intramuscular therapy
  • Adjunctive delivery routes

The clinical focus remains on practical treatment options for patients requiring additional support beyond standard antidepressants.

Sponsored Trials

Trial Name Country Status
Evaluation of Ademetionine Efficacy and Safety as Adjunctive Therapy in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled StudyItaly ItalyRecruiting
Evaluation of Ademetionine Intramuscular Injection as an Adjunctive Therapy to Antidepressants in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled StudyItaly ItalyRecruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
1
Exclusive Molecules
out of 2 total (50% not shared with other sponsors)

This sponsor works with 2 molecules, of which 1 is not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 15 sites collaborated multiple times

This sponsor has worked with 15 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Mental Disorders2 trials
    150 other sponsors

Partnered Research Centres

15 centres
location_city
assignment153
ASST Fatebenefratelli Sacco
Address
Via Giovanni Battista Grassi 74, 20157 Milan
Learn morearrow_forward
location_city
assignment392
Azienda Ospedaliera di Padova
Address
Via Nicolo' Giustiniani 2, 35128 Padua
Learn morearrow_forward
location_city
assignment134
Azienda Ospedaliera Nazionale Ss Antonio E Biagio E C Arrigo Alessandria
Address
Via Venezia 16, 15121 Alessandria
Learn morearrow_forward
location_city
assignment338
Azienda Ospedaliera Papa Giovanni XXIII
Address
Piazza Oms 1, 24127 Bergamo
Learn morearrow_forward
location_city
assignment292
Azienda Ospedaliero Universitaria Pisana
Address
Via Paradisa 2, 56124 Pisa
Learn morearrow_forward
location_city
assignment300
Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania
Address
Via Santa Sofia 78, 95123 Catania
Learn morearrow_forward
Page 1 of 3

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Mylan Inc..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.